SARS-COV-2
Clinical trials for SARS-COV-2 explained in plain language.
Never miss a new study
Get alerted when new SARS-COV-2 trials appear
Sign up with your email to follow new studies for SARS-COV-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Moderna infant COVID vaccine trial halted early
⭐️ VACCINE ⭐️ TerminatedThis study aimed to test the safety and effectiveness of Moderna's updated COVID-19 vaccine (mRNA-1273.214) in very young infants, aged 12 weeks to under 6 months. It planned to compare the babies' immune responses to those seen in adults from a previous study. However, the trial…
Matched conditions: SARS-COV-2
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 16, 2026 15:23 UTC
-
Early-Stop trial tests antibody cocktail for mild COVID cases
Disease control TerminatedThis study tested a new antibody combination treatment (REGN14256+imdevimab) for adults with mild COVID-19 who were otherwise healthy. The goal was to see if the treatment was safe and could help clear the virus faster and reduce symptoms. The trial was terminated early and only …
Matched conditions: SARS-COV-2
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Could a daily pill shield frontline workers from COVID?
Prevention TerminatedThis study tested whether a daily pill (Emtricitabine/Tenofovir) could prevent COVID-19 in healthcare workers at high risk of exposure. Over 1,300 participants were randomly assigned to receive either the pill or a placebo, in addition to standard safety measures like masks. The …
Matched conditions: SARS-COV-2
Phase: PHASE3 • Sponsor: Hospital Italiano de Buenos Aires • Aim: Prevention
Last updated Mar 23, 2026 15:15 UTC